Login / Signup
Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment.
Leonardo Calza
Vincenzo Colangeli
Eleonora Magistrelli
Nicolo' Rossi
Elena Rosselli Del Turco
Linda Bussini
Marco Borderi
Pierluigi Viale
Published in:
HIV clinical trials (2017)
The non-negligible prevalence of MS among HIV-infected patients under cART requires a careful and periodic monitoring of its components, with particular attention to dyslipidemia and hypertension.
Keyphrases
</>
hiv infected patients
antiretroviral therapy
hiv infected
metabolic syndrome
human immunodeficiency virus
hiv positive
risk factors
hiv aids
blood pressure
ms ms
skeletal muscle
hepatitis c virus
men who have sex with men